• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺隐匿性癌。对1020例连续尸检病例的评估。

Occult carcinomas of the thyroid. Evaluation of 1,020 sequential autopsies.

作者信息

Lang W, Borrusch H, Bauer L

机构信息

Department of Pathology, Medical School, Hannover, Federal Republic of Germany.

出版信息

Am J Clin Pathol. 1988 Jul;90(1):72-6. doi: 10.1093/ajcp/90.1.72.

DOI:10.1093/ajcp/90.1.72
PMID:3389346
Abstract

In a sequence of 1,020 autopsies, all thyroid glands were thoroughly examined during a two-year period. Fifty-seven percent of the thyroid glands had no gross or histologic changes; approximately 22% were more or less goitrous. In 63 of 1,020 (6.2%) thyroid glands, a clinically latent carcinoma was detected. The greatest diameter of tumors measured microscopically ranged between 0.5 and 10.5 mm. Sixty-nine percent of the carcinomas were found by excision of a local change of tissue visible through close examination by the naked eye. All but one carcinoma were of papillary type, the one exception being a C-cell carcinoma. Multicentricity was found in 46% and regional lymph node metastases in 14%. There was no significant predilection of sex or age. It was concluded that these tumors have no propensity to increase to a clinically apparent thyroid disease.

摘要

在为期两年的1020例尸检中,对所有甲状腺进行了全面检查。57%的甲状腺无大体或组织学改变;约22%或多或少有甲状腺肿。在1020例甲状腺中,有63例(6.2%)检测到临床隐匿性癌。显微镜下测量的肿瘤最大直径在0.5至10.5毫米之间。69%的癌是通过切除肉眼仔细检查可见的局部组织变化发现的。除1例外,所有癌均为乳头状癌,唯一的例外是C细胞癌。46%发现有多中心性,14%有区域淋巴结转移。无明显的性别或年龄倾向。得出的结论是,这些肿瘤没有发展为临床明显甲状腺疾病的倾向。

相似文献

1
Occult carcinomas of the thyroid. Evaluation of 1,020 sequential autopsies.甲状腺隐匿性癌。对1020例连续尸检病例的评估。
Am J Clin Pathol. 1988 Jul;90(1):72-6. doi: 10.1093/ajcp/90.1.72.
2
[Latent cancerous pathology of the thyroid].[甲状腺潜在癌病理]
Vopr Onkol. 1992;38(7):811-7.
3
Occult carcinoma of the thyroid. A systematic autopsy study from Spain of two series performed with two different methods.
Cancer. 1993 Jun 15;71(12):4022-9. doi: 10.1002/1097-0142(19930615)71:12<4022::aid-cncr2820711236>3.0.co;2-o.
4
The prevalence and significance of clinically unsuspected neoplasms in cervical lymph nodes.颈部淋巴结中临床未被怀疑的肿瘤的患病率及意义。
Head Neck. 2003 Oct;25(10):841-7. doi: 10.1002/hed.10304.
5
Occult thyroid carcinoma. A study of 160 autopsy cases. The first report for the region of Epirus-Greece.
Anticancer Res. 2002 Jan-Feb;22(1A):427-32.
6
Occult thyroid pathology in the young adult: an autopsy study of 138 patients without clinical thyroid disease.年轻成人隐匿性甲状腺病变:138例无临床甲状腺疾病患者的尸检研究
Hum Pathol. 1988 Jun;19(6):689-96. doi: 10.1016/s0046-8177(88)80175-8.
7
The prevalence of unsuspected thyroid pathology in 300 sequential autopsies, with special reference to the incidental carcinoma.300例连续尸检中未被怀疑的甲状腺病变的患病率,特别提及偶然发现的癌。
Cancer. 1989 Nov 1;64(9):1888-93. doi: 10.1002/1097-0142(19891101)64:9<1888::aid-cncr2820640922>3.0.co;2-c.
8
[Occult carcinoma of the thyroid gland: an epidemiological study of autopsy material].
Ann Ital Chir. 1990 Mar-Apr;61(2):141-6.
9
Not all "occult" papillary carcinomas are "minimal".并非所有“隐匿性”乳头状癌都是“微小癌”。
Surgery. 1988 Dec;104(6):971-6.
10
Thyroid ablation with 1.1 GBq (30 mCi) iodine-131 in patients with papillary thyroid carcinoma at intermediate risk for recurrence.对复发风险处于中等水平的甲状腺乳头状癌患者采用1.1吉贝可(30毫居里)碘-131进行甲状腺消融。
Thyroid. 2014 May;24(5):826-31. doi: 10.1089/thy.2013.0479. Epub 2014 Jan 24.

引用本文的文献

1
The myth of iodine: A systematic review and meta-analysis on the relationship between iodine and thyroid nodule.碘的神话:关于碘与甲状腺结节关系的系统评价和荟萃分析
J Endocrinol Invest. 2025 May 28. doi: 10.1007/s40618-025-02606-4.
2
Retrospective study from a single center to comparison of diagnostic value of three thyroid imaging reporting and data systems in Bethesda III/IV thyroid nodules.一项来自单一中心的回顾性研究,比较三种甲状腺影像报告和数据系统对贝塞斯达III/IV级甲状腺结节的诊断价值。
Front Oncol. 2025 Apr 11;15:1549646. doi: 10.3389/fonc.2025.1549646. eCollection 2025.
3
Thyroid Nodules: Diagnosis and Treatment in Primary Care.
甲状腺结节:基层医疗中的诊断与治疗
Dtsch Arztebl Int. 2025 Jun 27;112(13):341-347. doi: 10.3238/arztebl.m2025.0067.
4
Predicting disease-specific survival in patients undergoing active surveillance for papillary thyroid carcinoma.预测接受乳头状甲状腺癌主动监测患者的疾病特异性生存率。
World J Surg. 2025 Apr;49(4):1011-1021. doi: 10.1002/wjs.12434. Epub 2024 Dec 19.
5
Guidelines from the Brazilian society of surgical oncology regarding indications and technical aspects of neck dissection in papillary, follicular, and medullary thyroid cancers.巴西外科肿瘤学会关于甲状腺乳头、滤泡和髓样癌颈部清扫术适应证和技术方面的指南。
Arch Endocrinol Metab. 2023 May 12;67(4):e000607. doi: 10.20945/2359-3997000000607.
6
The Significance of Unsampled Microscopic Thyroid Carcinomas in Multinodular Goiter.多结节性甲状腺肿中未采样的微小甲状腺癌的意义
Endocr Pathol. 2023 Mar;34(1):119-128. doi: 10.1007/s12022-022-09743-z. Epub 2022 Dec 17.
7
Characteristics and Management of Papillary Thyroid Microcarcinoma in the United Arab Emirates: Experience from a Large Tertiary Hospital.阿拉伯联合酋长国甲状腺微小乳头状癌的特征与管理:来自一家大型三级医院的经验
Saudi J Med Med Sci. 2022 Jan-Apr;10(1):42-48. doi: 10.4103/sjmms.sjmms_393_21. Epub 2022 Jan 17.
8
Incidence, detection and outcome of differentiated thyroid cancer in Western Sweden.瑞典西部分化型甲状腺癌的发病、检出与结局。
BJS Open. 2021 Sep 6;5(5). doi: 10.1093/bjsopen/zrab099.
9
Diagnostic performance of US-based FNAB criteria of the 2020 Chinese guideline for malignant thyroid nodules: comparison with the 2017 American College of Radiology guideline, the 2015 American Thyroid Association guideline, and the 2016 Korean Thyroid Association guideline.2020年中国恶性甲状腺结节诊疗指南中基于超声的细针穿刺活检标准的诊断性能:与2017年美国放射学会指南、2015年美国甲状腺协会指南及2016年韩国甲状腺协会指南的比较
Quant Imaging Med Surg. 2021 Aug;11(8):3604-3618. doi: 10.21037/qims-20-1365.
10
Active surveillance for patients with very low-risk thyroid cancer.对极低风险甲状腺癌患者进行主动监测。
Laryngoscope Investig Otolaryngol. 2020 Feb 7;5(1):175-182. doi: 10.1002/lio2.356. eCollection 2020 Feb.